Kancera’s Fractaline Blockers May Fight Ovarian Cancer

Potential To Disrupt Cancer Cells' Resistance To Chemotherapy

 
• By Sten Stovall
  
Ovarian Cancer
Kancera CEO says proof-of-concept trials in cancer to begin in 2022 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D